|
|
Article: Funding Supports ADA Technologies' Development of Home Monitor for Bipolar Disorder.
- Article from:
- Diabetes Week
- Article date:
- November 9, 2009
CopyrightCOPYRIGHT 2009 NewsRX. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
ADA Technologies, Inc. (ADA) received a $189,886 grant from the National Institute of Mental Health to develop a home lithiummonitor for use by patients with bipolar disorder. The testing tool would allow reliable, routine at-home monitoring of blood lithium concentrations, enabling individuals with bipolar disorder to conveniently and effectively manage their care (see also ADA Technologies, Inc.).
Effective treatment of bipolar disorder, an inherited disease that affects 5.7 million adult Americans (www.mentalhealth.com), is dependent on maintaining a lithium blood concentration that falls within a narrow range. Current monitoring methods are not amenable to ...